Galectin Therapeutics
GALT
#8188
Rank
โ‚ฌ0.16 B
Marketcap
2,60ย โ‚ฌ
Share price
-3.37%
Change (1 day)
45.43%
Change (1 year)

EPS for Galectin Therapeutics (GALT)

EPS in 2023 (TTM): -0,62ย โ‚ฌ

According to Galectin Therapeutics's latest financial reports the company's current EPS (TTM) is -0,63ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -0,62ย โ‚ฌ a decrease over its 2021 EPS that were of -0,50ย โ‚ฌ.

EPS history for Galectin Therapeutics from 2002 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-0,62ย โ‚ฌ0.29%
2022-0,62ย โ‚ฌ25%
2021-0,50ย โ‚ฌ30%
2020-0,38ย โ‚ฌ-6.98%
2019-0,41ย โ‚ฌ13.16%
2018-0,36ย โ‚ฌ-22.45%
2017-0,47ย โ‚ฌ-35.53%
2016-0,73ย โ‚ฌ-13.64%
2015-0,84ย โ‚ฌ11.39%
2014-0,75ย โ‚ฌ-39.69%
2013-1,25ย โ‚ฌ81.94%
2012-0,69ย โ‚ฌ-32.08%
2011-1,01ย โ‚ฌ7.07%
2010-0,95ย โ‚ฌ-17.5%
2009-1,15ย โ‚ฌ150%
2008-0,46ย โ‚ฌ-68%
2007-1,43ย โ‚ฌ127.27%
2006-0,63ย โ‚ฌ-52.17%
2005-1,32ย โ‚ฌ-20.69%
2004-1,66ย โ‚ฌ52.63%
2003-1,09ย โ‚ฌ-13.64%
2002-1,26ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-12,24ย โ‚ฌ 1,842.42%๐Ÿ‡บ๐Ÿ‡ธ USA
-0,18ย โ‚ฌ-71.21%๐Ÿ‡บ๐Ÿ‡ธ USA